Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Albumine Infusion in the Prevention of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt

NCT01559519 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT01559519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01559519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Albumine Infusion in the Prevention of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
Lead sponsor
University of Roma La Sapienza
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2012
Completion date
December 31, 2013
Enrollment
20 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic encephalopathy